About the Journal

Translational Medicine Reports is a peer-reviewed international journal publishing articles in the field of molecular biology, biochemistry and nanotechnology applied to the treatment of chronic-degenerative diseases including diabetes, cancer, neurological, cardiovascular and metabolic disorders. The aim of the Journal is to contribute to bridging the gap between basic research and clinical applications from an interdisciplinary perspective. Translational Medicine Reports addresses researchers and managers in academia, biotechnology and pharmaceutical industry researchers, physician scientists, etc. Original Articles with interdisciplinary topics, Reviews, Editorials, From Bench-to-Bedside Articles, Conference Proceedings, and Letters to the Editor are welcome. Every article published in the Journal will be peer-reviewed by experts in the field and selected by members of the Editorial Board. 

The journal is completely free: no charge for publication, as it is supported by private funds.

Announcements

Ceased publication

5 June 2025

PAGEPress has planned an internal reconstruction in order to focus more carefully on the development of its journals and to achieve a better resources management.


Given the slow development of Translational Medicine Reports won’t accept any further submissions.


We would like to thank Editors, Authors and Reviewers for their commitment in shaping and promoting this publication.